We would recommend testing for IgLON5 antibodies only in cases of suspected PSP, which have atypical clinical features, such as stridor, dysphagia, or parasomnias, that are uncommon in PSP patients [15, 19, 24]. This evidence concerns the gene IGLON5 and supranuclear palsy, progressive, 1.